Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography

Administration of ketamine for unipolar and bipolar depression

(2017) Christoph Kraus et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE

Ketamine for Depression, 3: Does Chirality Matter?

(2017) Chittaranjan Andrade   JOURNAL OF CLINICAL PSYCHIATRY

Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice

(2017) T.H. Pham et al.   NEUROPHARMACOLOGY

Dose-response characteristics of intravenous ketamine on dissociative stereotypy, locomotion, sensorimotor gating, and nociception in male Sprague-Dawley rats

(2017) Kennett D. Radford et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation

(2016) Cristina Cusin et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review

(2016) Kristian Gaarn du Jardin et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression

(2016) Kristian Gaarn du Jardin et al.   PSYCHOPHARMACOLOGY

Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test

(2015) Yan Li et al.   BEHAVIOURAL BRAIN RESEARCH

High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People

(2015) Georg S. Kranz et al.   BIOLOGICAL PSYCHIATRY

How does ketamine elicit a rapid antidepressant response?

(2015) Ege T Kavalali et al.   CURRENT OPINION IN PHARMACOLOGY

Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases

(2015) Lucie Bartova et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Repeated ketamine administration redeems the time lag for citalopram's antidepressant-like effects

(2015) G.-F. Zhang et al.   EUROPEAN PSYCHIATRY

The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN

(2015) Kenichi Fukumoto et al.   NEUROPSYCHOPHARMACOLOGY

Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression

(2015) Bruno Romeo et al.   PSYCHIATRY RESEARCH

Lithium and Valproate Levels Do Not Correlate with Ketamine’s Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

(2015) Annie J. Xu et al.   NEURAL PLASTICITY

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

(2015) C Yang et al.   Translational Psychiatry

Meta-Analysis of Molecular Imaging of Serotonin Transporters in Major Depression

(2014) Gregor Gryglewski et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Effects of opioids on human serotonin transporters

(2014) M. Barann et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test

(2014) Kenichi Fukumoto et al.   PSYCHOPHARMACOLOGY

A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques

(2014) H Yamanaka et al.   Translational Psychiatry

History, background, concepts and current use of comedication and polypharmacy in psychiatry

(2013) H.-J. Möller et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

5-HT2A Receptors in the Feline Brain: 123I-5-I-R91150 Kinetics and the Influence of Ketamine Measured with Micro-SPECT

(2013) T. Waelbers et al.   JOURNAL OF NUCLEAR MEDICINE

Subanesthetic Doses of Ketamine Transiently Decrease Serotonin Transporter Activity: A PET Study in Conscious Monkeys

(2013) Shigeyuki Yamamoto et al.   NEUROPSYCHOPHARMACOLOGY

Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism

(2013) Valentina Gigliucci et al.   PSYCHOPHARMACOLOGY

Optimization of [11C]DASB-synthesis: Vessel-based and flow-through microreactor methods

(2012) Johanna Ungersboeck et al.   APPLIED RADIATION AND ISOTOPES

Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression

(2012) Carlos A. Zarate et al.   BIOLOGICAL PSYCHIATRY

Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression

(2012) James W. Murrough et al.   BIOLOGICAL PSYCHIATRY

Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression

(2012) Xiaochen Zhao et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET

(2012) R Lanzenberger et al.   MOLECULAR PSYCHIATRY

Normative database of the serotonergic system in healthy subjects using multi-tracer PET

(2012) Markus Savli et al.   NEUROIMAGE

Serotonin and molecular neuroimaging in humans using PET

(2011) Anne Saulin et al.   AMINO ACIDS

Simple and rapid preparation of [11C]DASB with high quality and reliability for routine applications

(2009) D. Haeusler et al.   APPLIED RADIATION AND ISOTOPES

Location of the Antidepressant Binding Site in the Serotonin Transporter

(2009) Jacob Andersen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function

(2008) Yejun Zhao et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Ketamine, But Not Phencyclidine, Selectively Modulates Cerebellar GABAA Receptors Containing  6 and   Subunits

(2008) W. Hevers et al.   JOURNAL OF NEUROSCIENCE

Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders

(2008) C Spindelegger et al.   MOLECULAR PSYCHIATRY